Cardiology

doi: 10.25005/2074-0581-2019-21-1-48-54
TREATMENT OF CHRONIC HEART FAILURE IN MIDDLE-AGED MEN WITH DEPRESSION

Kh.S. Sultonov1, Kh.Yo. Sharipova1, G.M. Negmatova2, A.A. Sherbadalov1, F.N. Abdulloev1,3, O.S. Nurulloev1,3

1Department of Propaedeutics of Internal Medicine, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2Department of Internal Diseases № 1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
3Departments of Neurology and Cardiorheumatology, City Medical Center № 2 named after Academician K.T. Tajiev, Dushanbe, Republic of Tajikistan

Objective: Comparative assessment of the efficiency of standard and combined antidepressant therapy of chronic heart failure (CHF), flowing depression in middle-aged men with mild and moderate arterial hypertension (AH).

Methods: Evaluation of the effectiveness of CHF treatment in patients with absence (Group I) and the presence of depressive disorders (Group II) and combined with antidepressants (paroxetine) of standard therapy for CHF occurring with depression (Group III) was spent. Clinical indices and structural parameters of the myocardium and vessels are studied in the dynamics

Results: In patients with depression not receiving antidepressants, the lack of depression is accompanied by low adherence to treatment and the meaningful by high BP. Despite the high efficacy of standard CHF treatment, the combination with an antidepressant (the importance of improving the structural parameters of the myocardium, reduction of depression and increased adherence to treatment), adherence to treatment is significantly lower than in patients with initial absence of depression

Conclusions: In the absence of depression, standard CHF therapy in middle-aged men with hypertension significantly improves the hemodynamic parameters and the reduced severity of heart failure. Against the background of depression, the effectiveness of CHF treatment (without an antidepressant) is lower: the level of depression, the left ventricular myocardial mass index, and intima-media thickness are much higher, treatment adherence and the ratio of maximum speeds of early and late filling (E/A) are lower than in comparison groups. Combined with paroxetine, standard CHF therapy in middle-aged men with depression, mild depression, and CHF, increases adherence to treatment, improves the structural parameters of the heart. However, adherence to the treatment is meaningful low than in patients who initially lacked depression, which dictates the need to develop effective measures to prevent depressions in patients with the risk of developing CHF.

Keywords: Male sex, middle age, chronic heart failure, hypertension, depression, antidepressant therapy.

Download file:


References
  1. Medvedev VE, Martynov SE, Zverev KV. Psikhosomaticheskie zabolevaniya v kardiologii (tipologiya i kliniko-dinamicheskie kharakteristiki) [Psychosomatic diseases in cardiology (typology and clinical and dynamic characteristics)]. Psikhiatriya i psikhofarmakoterapiya. 2012;4:34-41.
  2. Paraskevaidis I. Treating depression in coronary artery disease and chronic heart failure: what’s new in using selective serotonin re-uptake inhibitors? Cardiovasc Hematol Agents Med Chem. 2012;10(2):109-15
  3. Polikandrioti М, Christou A, Morou Z. Evaluation of depression in patients with heart failure. Health Sci J. 2010;4:37-47.
  4. Johnson TJ. Depression predicts repeated heart failure hospitalizations. J Card Fail. 2012;3(18):246-52.
  5. Fomin IV, Ageev FT. Epidemiologiya khronicheskoy serdechnoy nedostatochnosti v Rossiyskoy Federatsii [Epidemiology of chronic heart failure in the Russian Federation]. V: Khronicheskaya serdechnaya nedostatochnost’. Moscow, RF: GEOTAR-Media; 2010. p. 7-77.
  6. Zaya М, Phan А, Schwarz ER. Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol. 2012;4(2):23-30.
  7. Sultonov KhS, Sharipova KhYo, Negmatova GM. Techenie arterial’noy gipertonii u muzhchin srednego vozrasta [The course of arterial hypertension in middle-aged men]. Vestnik Avitsenny [Avicenna Bulletin]. 2015;1:55-60
  8. Sharipova KhYo, Zubaydov RN, Kiyomiddinov KhKh. Khronicheskaya serdechnaya nedostatochnost’, arterial’naya gipertoniya i remodelirovanie serdtsa [Chronic heart failure, arterial hypertension and heart remodeling]. Vestnik Avitsenny [Avicenna Bulletin]. 2010;2:71-5.
  9. Sharipova KhYo, Kiyomiddinov KhKh, Zubaydov RN. Remodelirovanie serdtsa i techeniye khronicheskoy serdechnoy nedostatochnosti [Heart remodeling and the course of chronic heart failure]. Uchyonye zapiski SPbGMU im. akad. I.P. Pavlova. 2011;2:162-3.
  10. Smulevich AB. Depressii pri psikhicheskikh i somaticheskikh zabolevaniyakh [Depression in mental and somatic diseases]. Moscow, RF: MIA; 2014. 540 p.
  11. Malkin CJ, Pugh PJ, Morris PD. Low serum testosterone and in-creased mortality in men with coronary heart disease. Heart. 2010;96(9):1821-5.
  12. Araujo AB, Dixon JM, Suarez EA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism. 2011;96(8):3007-19.
  13. Sultonov KhS, Sharipova KhYo, Negmatova GM. Effektivnost’ kontroliruemoy terapii arterial’noy gipertonii u lits srednego vozrasta [The effectiveness of controlled therapy of arterial hypertension in middle-aged people]. Vestnik Avitsenny [Avicenna Bulletin]. 2016;1:67-71.
  14. Baranov AP, Strutynskiy AV, Oynotkinova OSh. Vozmozhnosti terapii trevozhno-depressivnykh rasstroystv u bol’nykh s khronicheskoy serdechnoy nedostatochnost’yu [The possibilities of treatment of anxiety and depressive disorders in patients with chronic heart failure]. Kardiologiya. 2016;9:572–8.
  15. Natsional’nye rekomendatsii OSSN, RKO i RNMOT po diagnostike i lecheniyu KHSN (chetvyortyy peresmotr); utverzhdeny na kongresse OSSN 7 dekabrya 2012 goda, na pravlenii OSSN 31 marta 2013 i kongresse RKO 25 sentyabrya 2013 goda [National recommendations of OSSN, RKO and RNMOT for the diagnosis and treatment of CHF (fourth revision); approved at the OSSN congress on December 7, 2012, on the OSSN board on March 31, 2013, and the CSC congress on September 25, 2013]. Zhurnal serdechnaya nedostatochnost’. 2013;7:379-472.
  16. Efremova EV, Menzorov MV, Sabitov IA. Priverzhennost’ k lecheniyu bol’nykh s khronicheskoy serdechnoy nedostatochnost’yu v usloviyakh komorbidnosti [Adherence to treatment of patients with chronic heart failure in terms of comorbidity]. Klinicheskaya meditsina. 2015;93(9):20-4.
  17. Mancia G, Fagard R, Narkiewicz K. Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-357.
  18. Khamidov NKh, Umarov AA, Umarova SA, Toirov KhK. Osobennosti remodelirovaniya miokarda levogo zheludochka u bol’nykh s arterial’noy gipertoniey pozhilogo vozrasta s komorbidnoy depressiyey [Features of left ventricular myocardial remodeling in elderly patients with arterial hypertension with comorbid depression]. Vestnik Avitsenny [Avicenna Bulletin]. 2017;19(2):172-6. Available from: http://dx.doi. org/10.25005/2074-0581-2017-19-2-172-176.
  19. Umarov AA, Khamidov NKh, Umarova SA. Izolirovannaya sistolicheskaya arterial’naya gipertoniya: nekotorye aspekty patogeneza i faktorov riska [Isolated systolic arterial hypertension: some aspects of pathogenesis and risk factors]. Vestnik Avitsenny [Avicenna Bulletin]. 2011;2:130-4.
  20. Khamidov NKh, Khalikova NA, Khursanov NM, Makhadova KKh. Vliyanie reksetina na funktsional’nye parametry serdtsa u bol’nykh gipertonicheskoy bolezn’y u pozhilogo vozrasta s affektivnymi rasstroystvami [The effect of Rexetin on the functional parameters of the heart in elderly patients with essential hypertension with affective disorders]. Vestnik Akademii meditsinskikh nauk Tadzhikistana. 2012;4:9-14.
  21. Silver MA. Depression and heart failure: an overview of what we know and don’t know. Cleve Clin J Med. 2010;77(3):7-11.
  22. Allman E, Berry D, Nasir L. Depression and coping in heart failure patients: a review of the literature. J Cardiovasc Nurs. 2009;24(2):106-17.

Authors informations:

Sultonov Khabibullo Suvonovich , Assistant, Department of Propaedeutics of Internal Medicine, Avicenna Tajik State Medical University

Sharipova Khursand Yodgorovna , Doctor of Medical Sciences, Full Professor, Professor of the Department of Propedeutics of Internal Diseases, Avicenna Tajik State Medical University

Negmatova Gulnora Mansurovna , Assistant of the Department of Internal Diseases № 1, Avicenna Tajik State Medical University

Sherbadalov Akhmad Akhadovich , Postgraduate Student, Department of Propedeutics of Internal Diseases, Avicenna Tajik State Medical University

Abdulloev Firdavs Nazirovich , Head of the Department of Neurology of the City Medical Center № 2 named after Academician K.T. Tajiev; Competitor of the Department of Propedeutics of Internal Diseases, Avicenna Tajik State Medical University

Nurulloev Oraz Sadulloevich , Doctor at the Cardiorheumatology Department, City Medical Center № 2 named after Academician K.T. Tajiev; Competitor of the Department of Propedeutics of Internal Diseases, Avicenna Tajik State Medical University

Address for correspondence:

Sharipova Khursand Yodgorovna
Doctor of Medical Sciences, Full Professor, Professor of the Department of Propedeutics of Internal Diseases, Avicenna Tajik State Medical University

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: +992 (935) 811297

E-mail: sharipovakh@mail.ru

Materials on the topic: